A panel discussion led by Dr Kevin Cox, Chairman, Biorelate, with Dr Jina Swartz, Executive Medical Director, Therapeutic Area Head at MSD, and Dr Sheuli Porkess Executive Director, Research, Medical and Innovation, ABPI.
Monday 02 November 2020
10:00 - 11:30
COVID has resulted in an unprecedented increase in sharing of scientific information within the scientific community and with the public.
This panel looks at the challenges of this and the role of the scientific community in ensuring credibility.
We will examine 3 particular challenges:
1. The publication of as many papers as possible was a phenomenon seen before COVID. The COVID experience has amplified concerns about the reproducibility
of published studies3. What are the factors driving publication, and how much early research is visible? Are there differing opinions regarding the quality of
industry vs academic research, and can collaboration improve credibility? What is the place of pre-print publication in health research?
2. A survey conducted by the Open Knowledge Foundation found that, with respect to COVID-19, people "want data to be openly available for checking" and "are
more likely to listen to expert advice from scientists and researchers"1. Despite this, a July survey by YouGov indicated that 10% of the UK population would
refuse a COVID vaccine and 19% were undecided. What are the possible factors in this and what can the research community do?
3. Science advocacy contributes to public credibility but is that advocacy undermined by credibility issues within research? And what about the responsibilities of
the media in showcasing data – how can we trust what we read?
Join our event where these and other topics will be discussed by a panel representing the research community followed by a live Q&A session.’